Pfizer Vaccine For Kids May Not Be Approved Until November

The Wall Street Journal reports that Pfizer's application for FDA approval of a low-dose COVID-19 vaccine for children aged 5 to 11 is delayed. Originally aiming for approval by October, Pfizer submitted its data recently, but the full application may not be completed until mid-October. Consequently, the FDA's decision might be postponed until closer to Thanksgiving.

According to The Wall Street Journal, when is the FDA expected to make a decision on Pfizer's application?

• In December

• In November

• By the end of September

• By the end of October

What is the expected completion time for Pfizer's application for children aged 5 to 11?

• End of October

• Mid-October

• End of September

• Beginning of October

What was Pfizer's original goal for the vaccine approval for children?

• Approval by September

• Approval by October

• Approval by December

• Approval by November

When did Pfizer submit its data to the agency?

• Last week

• Yesterday

• Two days ago

• Last month

If the approval application is delayed until mid-October, when might a decision be expected?

• By Halloween

• By Thanksgiving

• By New Year

• By Christmas